Skip to main content
Have a personal or library account? Click to login
Use of histone deacetylase inhibitors (HDACis) in pancreatic ductal adenocarcinoma (PDAC): A narrative review Cover

Use of histone deacetylase inhibitors (HDACis) in pancreatic ductal adenocarcinoma (PDAC): A narrative review

Forum of Clinical Oncology
AHEAD OF PRINT
By:  and    
Open Access
|Jul 2025
Articles in this issue
DOI: https://doi.org/10.2478/fco-2024-0007 | Journal eISSN: 1792-362X | Journal ISSN: 1792-345X
Journal RSS Feed
Language: English
Submitted on: Oct 6, 2024
Accepted on: Dec 23, 2024
Published on: Jul 12, 2025
Published by: Helenic Society of Medical Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year
Keywords:
HDACis,
genetic transcription,
epigenetics,
acetylation,
PDAC
Related subjects:
Medicine,
Clinical medicine,
Internal medicine,
Haematology, oncology

© 2025 Vassiliki Tarara, Evangelos Karamitrousis, published by Helenic Society of Medical Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

AHEAD OF PRINT